Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a268797a9dcbd946727801bc0c9dc796 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70585 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd13a636a8792ee914c99b2478f525c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5aff61bb5217653b2a0a74230ee68bc |
publicationDate |
2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10900968-B2 |
titleOfInvention |
Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof |
abstract |
A method of prognosing and predicting breast cancer recurrence stratifies early stage ER+/PR+ and Her2− breast cancer patients with invasive ductal/lobular carcinoma of the breast into low risk or high risk for breast cancer recurrence by employing an IHC based assay which assesses or measures expression of a combination of 5 biomarkers and by employing a histopathological analysis which assesses 3 clinical prognostic parameters. |
priorityDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |